Status:
COMPLETED
Olmesartan as an add-on to Amlodipine in Hypertension
Lead Sponsor:
Sankyo Pharma Gmbh
Conditions:
Essential Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study is to test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with amlodipine alone
Eligibility Criteria
Inclusion
- Without antihypertensive pre-treatment mean seated BP greater than 160/100 mmHg
- Pre-treatment with amlodipine 5 or 10 mg: mean seated BP greater than or equal to 140/90 mmHg
Exclusion
- Secondary hypertension
- Any serious disorder which may limit the ability to evaluate the efficacy or safety of the test drugs
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
August 1 2007
Estimated Enrollment :
632 Patients enrolled
Trial Details
Trial ID
NCT00220233
Start Date
April 1 2005
End Date
August 1 2007
Last Update
December 24 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Leipzig, Germany
2
Sinsheim, Germany
3
Tann, Germany
4
Weinheim, Germany